Abstract: The present invention relates to an isolated humanized protein binding to human Glycoprotein VI (hGPVI) for treating a GPVI-related condition in a subject in need thereof, wherein said isolated humanized protein is to be administered during at least 2 hours to the subject, preferably during at least 4 to 6 hours.
Type:
Application
Filed:
February 2, 2018
Publication date:
December 5, 2019
Applicants:
Acticor Biotech, Université Paris Diderot - Paris 7, Université Paris-XIII, Nserm (Institut National de la Santé et de la Recherche Médicale), Université Paris-Sud 11
Inventors:
Philippe BILLIALD, Martine JANDROT-PERRUS, Gilles AVENARD
Abstract: The invention relates to a method of detecting dividing cells, or cells having the potential of dividing, in a cytological specimen stained using a Papanicolaou staining process, by the detection of a fluorescence signal coming from the membranes of these cells.
Type:
Grant
Filed:
June 30, 2010
Date of Patent:
December 3, 2013
Assignees:
Assistance Pulique-Hôpitaux de Paris, Centre National de la Recherche Scientifique, Université Paris-Sud 11